The government intends to launch Jan Samarth, a unified platform for the delivery of multiple initiatives with the objective of minimum government maximal governance.
Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. The Drugs Controller General of India (DCGI) approved India's first Quadri-valent Human Papillomavirus vaccine (qHPV) against cervical cancer.
The Board of Executive Directors of the World Bank has approved the financing of USD 250 million to support the "India State Support Program for Road Safety", a project by the Indian government to improve road safety.